102 related articles for article (PubMed ID: 12798317)
1. BR96 conjugates of highly potent anthracyclines.
King HD; Staab AJ; Pham-Kaplita K; Yurgaitis D; Firestone RA; Lasch SJ; Trail PA
Bioorg Med Chem Lett; 2003 Jul; 13(13):2119-22. PubMed ID: 12798317
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates.
King HD; Yurgaitis D; Willner D; Firestone RA; Yang MB; Lasch SJ; Hellström KE; Trail PA
Bioconjug Chem; 1999; 10(2):279-88. PubMed ID: 10077478
[TBL] [Abstract][Full Text] [Related]
3. Formation of squaric acid amides of anthracycline antibiotics. Synthesis and cytotoxic properties.
Tevyashova A; Sztaricskai F; Batta G; Herczegh P; Jeney A
Bioorg Med Chem Lett; 2004 Sep; 14(18):4783-9. PubMed ID: 15324908
[TBL] [Abstract][Full Text] [Related]
4. Influence of the structure of new anthracycline antibiotics on their biological properties.
Wasowska M; Oszczapowicz I; Wietrzyk J; Opolski A; Madej J; Dzimira S; Oszczapowicz J
Anticancer Res; 2005; 25(3B):2043-8. PubMed ID: 16158943
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory activity of four demethoxy fluorinated anthracycline analogs against five human-tumor cell lines.
Horton D; Khare A
Bioorg Med Chem Lett; 2010 Nov; 20(21):6179-81. PubMed ID: 20850305
[TBL] [Abstract][Full Text] [Related]
6. A short and efficient transformation of rhamnose into activated daunosamine, acosamine, ristosamine and epi-daunosamine derivatives, and synthesis of an anthracycline antibiotic acosaminyl-epsilon-iso-rhodomycinone.
Renneberg B; Li YM; Laatsch H; Fiebig HH
Carbohydr Res; 2000 Dec; 329(4):861-72. PubMed ID: 11125829
[TBL] [Abstract][Full Text] [Related]
7. Attachment of rhodosaminylanthracyclinone-type anthracyclines to the hinge region of monoclonal antibodies.
Hermentin P; Doenges R; Gronski P; Bosslet K; Kraemer HP; Hoffmann D; Zilg H; Steinstraesser A; Schwarz A; Kuhlmann L
Bioconjug Chem; 1990; 1(2):100-7. PubMed ID: 2095207
[TBL] [Abstract][Full Text] [Related]
8. Different toxicity profiles for drug- versus radionuclide-conjugated BR96 monoclonal antibodies in a syngeneic rat colon carcinoma model.
Nilsson R; Eriksson SE; Sjögren HO; Tennvall J
Acta Oncol; 2011 Jun; 50(5):711-8. PubMed ID: 21214493
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic activity of some glycoconjugates including saponins and anthracyclines.
Ekholm FS; Berényi Á; Lagerquist L; Saloranta T; Zupkó I; Schneider G; Wölfling J; Leino R
Carbohydr Res; 2012 Jul; 356():295-8. PubMed ID: 22520504
[TBL] [Abstract][Full Text] [Related]
10. Stabilization of chimeric BR96-doxorubicin immunoconjugate.
Barbour NP; Paborji M; Alexander TC; Coppola WP; Bogardus JB
Pharm Res; 1995 Feb; 12(2):215-22. PubMed ID: 7784336
[TBL] [Abstract][Full Text] [Related]
11. New hydrazone derivatives of adriamycin and their immunoconjugates--a correlation between acid stability and cytotoxicity.
Kaneko T; Willner D; Monkovíc I; Knipe JO; Braslawsky GR; Greenfield RS; Vyas DM
Bioconjug Chem; 1991; 2(3):133-41. PubMed ID: 1932212
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: inhibition of aggregation by methoxytriethyleneglycol chains.
King HD; Dubowchik GM; Mastalerz H; Willner D; Hofstead SJ; Firestone RA; Lasch SJ; Trail PA
J Med Chem; 2002 Sep; 45(19):4336-43. PubMed ID: 12213074
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antiproliferative effects of a 4'-morpholino-9-methyl anthracycline.
Nafziger J; Averland G; Bertounesque E; Gaudel G; Monneret C
J Antibiot (Tokyo); 1995 Oct; 48(10):1185-7. PubMed ID: 7490233
[No Abstract] [Full Text] [Related]
14. Generation of an intensely potent anthracycline by a monoclonal antibody-beta-galactosidase conjugate.
Torgov MY; Alley SC; Cerveny CG; Farquhar D; Senter PD
Bioconjug Chem; 2005; 16(3):717-21. PubMed ID: 15898742
[TBL] [Abstract][Full Text] [Related]
15. Randomized phase II study of BR96-doxorubicin conjugate in patients with metastatic breast cancer.
Tolcher AW; Sugarman S; Gelmon KA; Cohen R; Saleh M; Isaacs C; Young L; Healey D; Onetto N; Slichenmyer W
J Clin Oncol; 1999 Feb; 17(2):478-84. PubMed ID: 10080588
[TBL] [Abstract][Full Text] [Related]
16. A new class of semisynthetic anthracycline glycoside antibiotics incorporating a squaric acid moiety.
Sztaricskai F; Sum A; Roth E; Pelyvás IF; Sándor S; Batta G; Herczegh P; Reményi J; Miklán Z; Hudecz F
J Antibiot (Tokyo); 2005 Nov; 58(11):704-14. PubMed ID: 16466024
[TBL] [Abstract][Full Text] [Related]
17. (6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin.
Willner D; Trail PA; Hofstead SJ; King HD; Lasch SJ; Braslawsky GR; Greenfield RS; Kaneko T; Firestone RA
Bioconjug Chem; 1993; 4(6):521-7. PubMed ID: 7508268
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of monoclonal antibody conjugates of the calicheamicins: a novel and potent family of antitumor antibiotics.
Hinman LM; Hamann PR; Wallace R; Menendez AT; Durr FE; Upeslacis J
Cancer Res; 1993 Jul; 53(14):3336-42. PubMed ID: 8324745
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of antibody-drug conjugates comprised of potent camptothecin analogues.
Burke PJ; Senter PD; Meyer DW; Miyamoto JB; Anderson M; Toki BE; Manikumar G; Wani MC; Kroll DJ; Jeffrey SC
Bioconjug Chem; 2009 Jun; 20(6):1242-50. PubMed ID: 19469529
[TBL] [Abstract][Full Text] [Related]
20. Cure of SCID mice bearing human B-lymphoma xenografts by an anti-CD74 antibody-anthracycline drug conjugate.
Griffiths GL; Mattes MJ; Stein R; Govindan SV; Horak ID; Hansen HJ; Goldenberg DM
Clin Cancer Res; 2003 Dec; 9(17):6567-71. PubMed ID: 14695162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
